INZ-701, INZ-701
INZ701-105
Phase 3 small_molecule active
Quick answer
INZ-701, INZ-701 for Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active